SummaryZhejiang Jiangnan Pharmaceutical Machinery Co., Ltd. is identified as a Chinese limited-company manufacturer based in Zhejiang, established in 1997, with approximately 180 employees and more than 10 production lines. Its product scope covers pharmaceutical and packaging machinery, including capsule filling, tablet pressing, coating, granulation, cartoning, and related equipment. The supplier reports ISO9001:2008 certification; another company description also mentions GMP and CE certifications, although their validity is not independently detailed in the provided information. Export sales represent 41%–50% of total sales, indicating established international trade activity. Evidence confirms manufacturing scale and a broad machinery portfolio, but is insufficient to assess after-sales service, customization, innovation, or overall financial credibility. One buyer and Kazakhstan-related trade information are provided, but these do not establish a broad customer track record.
Supplier typeThe supplier is explicitly identified as a limited company and manufacturer, operating in pharmaceutical machinery, industrial equipment, manufacturing machinery, and packaging-related sectors. Its stated products include capsule filling machines, tablet presses, coating machines, granulators, blenders, and cartoning machines.
CertificationsThe supplier reports an ISO9001:2008 management-system certificate. A separate company description also lists GMP and CE certifications, but the provided data does not give detailed certificate validity or scope for those additional certifications.
R&D capabilityThe supplier description lists recognition as a national high-tech enterprise and a Zhejiang high-tech enterprise, which is positive evidence of technology-related standing. However, no specific R&D investment, patents, new product launches, or technical development results are provided.
Production capacityThe supplier reports approximately 180 employees, a manufacturing plant, more than 10 production lines, and a product portfolio spanning multiple pharmaceutical machinery categories. These details explicitly support established manufacturing capability, although the reported annual output is described only as below a stated threshold and production volume by product is unavailable.